http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111138557-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2020-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111138557-B |
| titleOfInvention | Gardenia polysaccharide and preparation method and application thereof |
| abstract | The invention discloses gardenia polysaccharide and an extraction method thereof. The gardenia polysaccharide comprises the following raw materials in percentage by mass: the total sugar content is 41-56%, uronic acid content is 34-45%, and protein content is 7-10%. The preparation method of the gardenia polysaccharide comprises the following steps: pulverizing fructus Gardeniae, defatting, extracting with water, precipitating with ethanol, freeze thawing repeatedly to remove protein, dialyzing, and freeze drying. The gardenia polysaccharide prepared by the invention can improve cholestatic liver injury induced by alpha-naphthyl isothiocyanate (ANIT) and 3,5-diethoxycarbonyl-1, 4-dihydro-2, 4, 6-trimethylpyridine (DDC) and alleviate carbon tetrachloride (CCL) 4 ) Induced fibrosis, and the liver protection effect of the gardenia polysaccharide is not reported in documents, which indicates that the gardenia polysaccharide has obvious prospect in preparing liver protection medicaments, in particular in preparing medicaments for resisting cholestatic liver injury and hepatic fibrosis. |
| priorityDate | 2020-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.